FT3 combined with the TyG index for risk stratification of mild cognitive impairment in euthyroid patients with type 2 diabetes - Poll - MDSpire

FT3 combined with the TyG index for risk stratification of mild cognitive impairment in euthyroid patients with type 2 diabetes

  • By

  • Yi Su

  • Lu Chen

  • Jing Huang

  • Haorui Lyu

  • Wei Feng

  • Jun Zhan

  • Yuyao Li

  • Zhanyi Ye

  • Xuan Liu

  • Changjiang Ying

  • June 22, 2026

  • 0 min

Share

Original Source(s)

FT3 combined with the TyG index for risk stratification of mild cognitive impairment in euthyroid patients with type 2 diabetes

  • by Yi Su, Lu Chen, Jing Huang, Haorui Lyu, Wei Feng, Jun Zhan, Yuyao Li, Zhanyi Ye, Xuan Liu, Changjiang Ying

  • June 22, 2026

Related Content

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

Early Proteomic and Metabolomic Signatures in Diabetes Associated with Progression to Diabetic Retinopathy Over 1–2 Years